bioAffinity Technologies, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $13.2M | $1.5M | $1.4M |
| FY2022 | $1.1M | $12.2M | $11.4M |
| FY2023 | $3.4M | $8.2M | $2.8M |
| FY2024 | $3.9M | $6.5M | $1.1M |
| FY2025 | $3.7M | $11.0M | $6.4M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $13.2M | $1.5M | $1.4M |
| FY2022 | $1.1M | $12.2M | $11.4M |
| FY2023 | $3.4M | $8.2M | $2.8M |
| FY2024 | $3.9M | $6.5M | $1.1M |
| FY2025 | $3.7M | $11.0M | $6.4M |